Articles, App Notes, Case Studies, & White Papers
-
Solid Form Screening, Rapid Formulation Selection To Meet Tight Timelines
A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.
-
Ophthalmic Formulation Development: Inside Ophthalmic Preparation
8/10/2022
Understand why the demand for CDMOs with experience in the formulation of ophthalmic products is on the rise.
-
Single Source Partner: Seamless Approach To Deliver World-Class Treatment
5/5/2022
Growing demand for high-value, complex therapies requires the right containment and delivery systems: solutions that offer superior quality and patient comfort while meeting stringent regulatory requirements.
-
Partnering With Clinicians To Improve Pediatric Formulation Development
6/13/2022
Greater collaboration between formulation experts and clinical colleagues, including healthcare professionals, is advocated to lead to safe and effective, age-appropriate medicinal products.
-
Inspection Of Injectable Products For Visible Particulates
8/8/2023
Examine the risks posed by particulates, the potential sources and types of particulates, and approaches to detect and measure visible particulates in injectables.
-
Stainless Steel Needles: Quantifying Cobalt Risk For EU Regulation
Learn how a partner who is committed to ensuring the safety of medical devices by mitigating the risk of chemical interaction with drugs is crucial for navigating the regulatory pathway to approval.
-
Transitioning From Vial To Prefilled Syringe
Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.
-
Understanding Of Amorphous Solid Dispersions & Their Downstream Development
2/7/2022
Understanding the properties of ASDs and their relationship to the downstream product scale up, stability, and in-vivo performance is critical to successfully utilize them for drug delivery of insoluble drugs.
-
Vials Vs. Cryobags For Cryopreservation Of Therapeutically Relevant T Cells
7/20/2023
Explore how COP 50 mL vials could serve as a basis for cell therapies and storage solution to help facilitate the manufacture and commercialization of cell products.
-
A Glass Package Designed Specifically for Pharmaceutical Use
A comprehensive solution for multiple glass quality issues that affect drug products is essential to avoid costly delays and drug product recalls, all while increasing patient safety.